A Novel Integrated Active Herbal Formulation Ameliorates Dry Eye Syndrome by Inhibiting Inflammation and Oxidative Stress and Enhancing Glycosylated Phosphoproteins in Rats

Dry eye syndrome (DES) is a chronic condition of the eye with insufficient production of tears leading to inadequate lubrication of eyes. Symptoms of DES are associated with discomfort and redness of the eye, blurred vision, and tear film instability which leads to the damaged ocular surface. Inflam...

Full description

Saved in:
Bibliographic Details
Main Authors: Omer Ersin Muz (Author), Cemal Orhan (Author), Fusun Erten (Author), Mehmet Tuzcu (Author), Ibrahim Hanifi Ozercan (Author), Prafull Singh (Author), Abhijeet Morde (Author), Muralidhara Padigaru (Author), Deshanie Rai (Author), Kazim Sahin (Author)
Format: Book
Published: MDPI AG, 2020-10-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_c7d44ae040ff4d0e8bbb16f8e371f8b7
042 |a dc 
100 1 0 |a Omer Ersin Muz  |e author 
700 1 0 |a Cemal Orhan  |e author 
700 1 0 |a Fusun Erten  |e author 
700 1 0 |a Mehmet Tuzcu  |e author 
700 1 0 |a Ibrahim Hanifi Ozercan  |e author 
700 1 0 |a Prafull Singh  |e author 
700 1 0 |a Abhijeet Morde  |e author 
700 1 0 |a Muralidhara Padigaru  |e author 
700 1 0 |a Deshanie Rai  |e author 
700 1 0 |a Kazim Sahin  |e author 
245 0 0 |a A Novel Integrated Active Herbal Formulation Ameliorates Dry Eye Syndrome by Inhibiting Inflammation and Oxidative Stress and Enhancing Glycosylated Phosphoproteins in Rats 
260 |b MDPI AG,   |c 2020-10-01T00:00:00Z. 
500 |a 10.3390/ph13100295 
500 |a 1424-8247 
520 |a Dry eye syndrome (DES) is a chronic condition of the eye with insufficient production of tears leading to inadequate lubrication of eyes. Symptoms of DES are associated with discomfort and redness of the eye, blurred vision, and tear film instability which leads to the damaged ocular surface. Inflammation and oxidative stress play a significant role in the pathogenesis of the disease. In this study, the protective effect of different doses (100 or 200 mg/kg) of a novel multi-component oral formulation of lutein/zeaxanthin, curcumin, and vitamin D3 (LCD) was evaluated using a rat model with benzalkonium chloride (BAC)-induced dry eye syndrome. The formulation was administered orally to rats for 4 weeks. We observed a significant improvement in tear volume, tear breakup time, tear film integrity, and reduction in overall inflammation in rats fed with the LCD at dose 200 mg/kg performing better than 100 mg/kg. Furthermore, the formulation helped in lowering oxidative stress by increasing antioxidant levels and restored protective tear protein levels including MUC1, MUC4, and MUC5AC with 200 mg of LCD having the most significant effect. The results strongly suggest that the combination of lutein/zeaxanthin, curcumin, and vitamin-D3 is effective in alleviating the symptoms of dry eye condition with a multi-modal mechanism of action. 
546 |a EN 
690 |a inflammation 
690 |a oxidative stress 
690 |a lutein 
690 |a curcumin 
690 |a vitamin D3 
690 |a dry eye syndrome 
690 |a Medicine 
690 |a R 
690 |a Pharmacy and materia medica 
690 |a RS1-441 
655 7 |a article  |2 local 
786 0 |n Pharmaceuticals, Vol 13, Iss 10, p 295 (2020) 
787 0 |n https://www.mdpi.com/1424-8247/13/10/295 
787 0 |n https://doaj.org/toc/1424-8247 
856 4 1 |u https://doaj.org/article/c7d44ae040ff4d0e8bbb16f8e371f8b7  |z Connect to this object online.